Works matching IS 2160763X AND DT 2015 AND VI 4 AND IP 5

Results: 11

Single- and multiple-dose study to evaluate pharmacokinetics, safety and tolerability in healthy volunteers: A comparison of extended-release oxycodone with sequestered naltrexone 40 mg twice daily to oxycontin 40 mg twice daily and extended-release oxycodone with sequestered naltrexone 80 mg once daily

Published in:

Clinical Pharmacology in Drug Development, 2015, v. 4, n. 5, p. 361, doi. 10.1002/cpdd.179

By:

Gandelman, Kuan;
Lamson, Michael;
Bramson, Candace;
Matschke, Kyle;
Salageanu, Joanne;
Malhotra, Bimal

Publication type:

Article

Developing antisense oligonucleotide and short-interfering RNA therapeutics - a few considerations.

Published in:

2015

By:

Cotreau, Monette M.

Publication type:

Editorial

Evaluation of the effect of multiple doses of rifampin on the pharmacokinetics and safety of ponatinib in healthy subjects.

Published in:

Clinical Pharmacology in Drug Development, 2015, v. 4, n. 5, p. 354, doi. 10.1002/cpdd.182

By:

Narasimhan, Narayana I.;
Dorer, David J.;
Davis, Jeffrey;
Turner, Christopher D.;
Sonnichsen, Daryl

Publication type:

Article

Quantitation of the impact of CYP3A5 A6986G polymorphism on quetiapine pharmacokinetics by simulation of target attainment.

Published in:

Clinical Pharmacology in Drug Development, 2015, v. 4, n. 5, p. 387, doi. 10.1002/cpdd.172

By:

Shilbayeh, Sireen A.R.;
Sy, Sherwin K.B.;
Melhem, Murad;
Zmeili, Rawan;
Derendorf, Hartmut

Publication type:

Article

Issue Information.

Published in:: 2015
Publication type:: Other

Evaluation of the effect of food and age on the pharmacokinetics of oral netupitant and palonosetron in healthy subjects: A randomized, open-label, crossover phase 1 study.

Published in:

Clinical Pharmacology in Drug Development, 2015, v. 4, n. 5, p. 377, doi. 10.1002/cpdd.192

By:

Calcagnile, Selma;
Lanzarotti, Corinna;
Gutacker, Michaela;
Jakob‐Rodamer, Verena;
Peter Kammerer, Klaus;
Timmer, Wolfgang

Publication type:

Article

Inhibition of prostacyclin and thromboxane biosynthesis in healthy volunteers by single and multiple doses of acetaminophen and indomethacin.

Published in:

Clinical Pharmacology in Drug Development, 2015, v. 4, n. 5, p. 337, doi. 10.1002/cpdd.194

By:

Schwartz, Jules I.;
Musser, Bret J.;
Tanaka, Wesley K.;
Taggart, William V.;
Mehta, Anish;
Gottesdiener, Keith M.;
Greenberg, Howard E.

Publication type:

Article

Single-dose pharmacokinetics of bupropion hydrobromide and metabolites in healthy adolescent and adult subjects.

Published in:

Clinical Pharmacology in Drug Development, 2015, v. 4, n. 5, p. 346, doi. 10.1002/cpdd.195

By:

Oh, D. Alexander;
Crean, Christopher S.

Publication type:

Article

Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended release formulation of oxycodone with sequestered naltrexone.

Published in:

Clinical Pharmacology in Drug Development, 2015, v. 4, n. 5, p. 370, doi. 10.1002/cpdd.177

By:

Gandelman, Kuan;
Lamson, Michael;
Salageanu, Joanne;
Bramson, Candace;
Matschke, Kyle;
Malhotra, Bimal

Publication type:

Article

Single- and multiple-dose pharmacokinetics of tofacitinib in healthy Chinese volunteers.

Published in:

Clinical Pharmacology in Drug Development, 2015, v. 4, n. 5, p. 395, doi. 10.1002/cpdd.202

By:

Krishnaswami, Sriram;
Wang, Tao;
Yuan, Yi;
Alvey, Christine W.;
Checchio, Tina;
Peterson, Mark;
Shi, Haihong;
Riese, Richard

Publication type:

Article

Identification of new oral dosing regimens for the neuraminidase inhibitor oseltamivir in patients with moderate and severe renal impairment.

Published in:

Clinical Pharmacology in Drug Development, 2015, v. 4, n. 5, p. 326, doi. 10.1002/cpdd.203

By:

Kamal, Mohamed A.;
Brennan, Barbara J.;
Subramoney, Vishak;
Lien, Yi Ting (Kayla);
Morcos, Peter N.;
Frey, Nicolas;
Rayner, Craig R.

Publication type:

Article